* Nsclc Targeted Therapy Review (updated 2024-10-14) ~ youtor.org

Nsclc Targeted Therapy Review (updated 2024-10-14)

KRAS NSCLC Details and Diagnosis Targeted Therapies in Lung Cancer 2023 [upl. by Coffee]

KRAS NSCLC Details and Diagnosis Targeted Therapies in Lung Cancer 2023

Duration: 10:03
62 weergaven | 6 okt. 2023

QampA Are There Ongoing Trials for Rare NSCLC Mutations Targeted Therapies in Lung Cancer 2023 [upl. by Dnyletak]

QampA Are There Ongoing Trials for Rare NSCLC Mutations Targeted Therapies in Lung Cancer 2023

Duration: 2:49
18 weergaven | 25 aug. 2023

Biomarkers in NSCLC Targeted Therapies in Lung Cancer 2023 youtubeshorts shorts [upl. by Aker]

Biomarkers in NSCLC Targeted Therapies in Lung Cancer 2023 youtubeshorts shorts

Duration: 0:31
110 weergaven | 28 aug. 2023

QampA Is Biomarker Testing Common in Early Stage NSCLC Targeted Therapies in Lung Cancer 2023 [upl. by Cook]

QampA Is Biomarker Testing Common in Early Stage NSCLC Targeted Therapies in Lung Cancer 2023

Duration: 4:57
22 weergaven | 25 aug. 2023

NonSmall Cell Lung Cancer Zofia Piotrowska MD MHS [upl. by Sew26]

NonSmall Cell Lung Cancer Zofia Piotrowska MD MHS

Duration: 53:16
53 weergaven | 6 maanden geleden

Targeted therapy for ALKpositive NSCLC A practical case study Biomarkerguided therapy in NSC [upl. by Mulligan]

Targeted therapy for ALKpositive NSCLC A practical case study Biomarkerguided therapy in NSC

Duration: 6:28
6 weergaven | 2 maanden geleden

Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC to Address Unmet Needs [upl. by Ajnat]

Taking Aim With the Next Wave of Antibody–Drug Conjugates in NSCLC to Address Unmet Needs

Duration: 48:40
312 weergaven | 10 maanden geleden

What Are Some Local Therapy Options for Patients with NSCLC Targeted Therapies in Lung Cancer [upl. by Garey]

What Are Some Local Therapy Options for Patients with NSCLC Targeted Therapies in Lung Cancer

Duration: 3:26
49 weergaven | 28 aug. 2023

Recent drug approvals for NSCLC [upl. by Orfinger]

Recent drug approvals for NSCLC

Duration: 0:49
187 weergaven | 10 jan. 2022

Management of NonSmall Cell Lung Cancer NSCLC with an EGFR Mutation — Karen Reckamp MD MS [upl. by Aloivaf]

Management of NonSmall Cell Lung Cancer NSCLC with an EGFR Mutation — Karen Reckamp MD MS

Duration: 34:23
423 weergaven | 4 maanden geleden

The Future of RET NSCLC Treatment Targeted Therapies in Lung Cancer 2023 [upl. by Nosna]

The Future of RET NSCLC Treatment Targeted Therapies in Lung Cancer 2023

Duration: 3:02
51 weergaven | 13 sep. 2023

The future of chemoimmunotherapy in resectable nonsmall cell lung cancer [upl. by Aiek]

The future of chemoimmunotherapy in resectable nonsmall cell lung cancer

Duration: 0:34
9 weergaven | 2 weken geleden

Maximizing the Impact of EGFRTargeted Therapy in Resectable NSCLC [upl. by Ianteen993]

Maximizing the Impact of EGFRTargeted Therapy in Resectable NSCLC

Duration: 43:35
507 weergaven | 30 mei 2023

Latest in the surgical management of earlystage lung cancer NSCLC review of the current science [upl. by Lednek]

Latest in the surgical management of earlystage lung cancer NSCLC review of the current science

Duration: 11:09
49 weergaven | 3 maanden geleden

Relevant New Data Sets and Advances in Targeted Therapy for NonSmall Cell Lung Cancer [upl. by Adiesirb]

Relevant New Data Sets and Advances in Targeted Therapy for NonSmall Cell Lung Cancer

Duration: 1:00:49
216 weergaven | 4 maanden geleden

Treatment Options amp Study Data for Patients with ROS1 NSCLC Targeted Therapies in Lung Cancer 2023 [upl. by Nakre]

Treatment Options amp Study Data for Patients with ROS1 NSCLC Targeted Therapies in Lung Cancer 2023

Duration: 10:50
181 weergaven | 12 sep. 2023

Biomarker Driven Therapy for NSCLC Targeted Therapies in Lung Cancer 2023 [upl. by Noami]

Biomarker Driven Therapy for NSCLC Targeted Therapies in Lung Cancer 2023

Duration: 4:48
214 weergaven | 14 aug. 2023

Outcomes and pCR after chemoimmunotherapy in resectable NSCLC [upl. by Eioj]

Outcomes and pCR after chemoimmunotherapy in resectable NSCLC

Duration: 1:53
24 weergaven | 2 weken geleden

Case Review IOBased Therapy in KRAS STK11 or KEAP mutated NSCLC [upl. by Seravart]

Case Review IOBased Therapy in KRAS STK11 or KEAP mutated NSCLC

Duration: 13:45
127 weergaven | 27 sep. 2023

Krystal 7 Study Adagrasib Pembrolizumab for KRAS G12C NSCLC Targeted Therapies in Lung Cancer [upl. by Fiel]

Krystal 7 Study Adagrasib Pembrolizumab for KRAS G12C NSCLC Targeted Therapies in Lung Cancer

Duration: 2:40
87 weergaven | 9 okt. 2023

What is Acquired Resistance to Targeted Therapy and Why Does it Occur [upl. by Auoz]

What is Acquired Resistance to Targeted Therapy and Why Does it Occur

Duration: 26:54
400 weergaven | 14 dec. 2015

Decoding HER2 in NSCLC Advances in biomarker testing and targeted therapies [upl. by Candice]

Decoding HER2 in NSCLC Advances in biomarker testing and targeted therapies

Duration: 36:45
60 weergaven | 2 maanden geleden

Paradigm Changes in the Perioperative Setting for Nonsmall Cell Lung Cancer Karen Reckamp MD [upl. by Inot]

Paradigm Changes in the Perioperative Setting for Nonsmall Cell Lung Cancer Karen Reckamp MD

Duration: 22:53
227 weergaven | 6 maanden geleden

Therapeutic Approaches for Patients with NSCLC — Justin F Gainor MD [upl. by Nimzay]

Therapeutic Approaches for Patients with NSCLC — Justin F Gainor MD

Duration: 52:58
167 weergaven | 4 maanden geleden

亞洲各國肺癌標靶藥物及基因檢測的保險與健保給付概況 Insurance and Health of NSCLC Targeted Therapy and NGS in Asian Countries [upl. by Nollat556]

亞洲各國肺癌標靶藥物及基因檢測的保險與健保給付概況 Insurance and Health of NSCLC Targeted Therapy and NGS in Asian Countries

Duration: 8:50
1,7K weergaven | 3 maanden geleden

Role of Maintenance Therapy in Advanced NSCLC Dr Corey Langer [upl. by Damien77]

Role of Maintenance Therapy in Advanced NSCLC Dr Corey Langer

Duration: 21:02
186 weergaven | 29 apr. 2013

Targeted therapy for NTRK fusionpositive cancers [upl. by Ttesil892]

Targeted therapy for NTRK fusionpositive cancers

Duration: 10:29
69 weergaven | 8 maanden geleden

Expanding HER2 horizons Implications for NSCLC and beyond [upl. by Nylarej]

Expanding HER2 horizons Implications for NSCLC and beyond

Duration: 40:57
3 weergaven | 1 week geleden

Optimal approaches for resectable ALKdriven NSCLC Biomarkerguided therapy in NSCLC and beyond [upl. by Adoc]

Optimal approaches for resectable ALKdriven NSCLC Biomarkerguided therapy in NSCLC and beyond

Duration: 9:40
633 weergaven | 2 maanden geleden

Alecensa Targeted Therapy for ALKPositive Lung Cancer [upl. by Anayad104]

Alecensa Targeted Therapy for ALKPositive Lung Cancer

Duration: 4:23
2,2K weergaven | 2 aug. 2023

YTube is the largest video sharing platform on the Internet. Millions of new videos appear on it every day. You can find a wide variety of videos, but YTube does not offer a FREE download service Our site allows you to download your favorite YTube videos in MP3 (audio) or MP4 (video) format in the most efficient way. You can find your favorite videos using "search" to download them.

New on site

Content Report
youtor.org / Youtor Videos converter © 2024

5